V

Viking Therapeutics
D

VKTX

52.600
USD
0.97
(1.88%)
مغلق
حجم التداول
89,412
الربح لكل سهم
-1
العائد الربحي
-
P/E
-56
حجم السوق
5,861,553,798
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -22.650
    (-8.77%)
    235.480 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    G
    GNFT
    -1.05000
    (-18.01%)
    4.78000 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    I
    ICPT
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار

العنوان: Viking Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.